Sascan Meditech

What Sascan Meditech does

Sascan Meditech Pvt. Ltd. is an Indian medtech startup founded in 2015 by laser scientist Dr Subhash Narayanan, headquartered at the SCTIMST-TIMed incubator in Thiruvananthapuram, Kerala. The company develops multimodal optical imaging devices for early cancer detection, anchored by OralScan — a CE-marked handheld device combining diffuse reflectance and tissue autofluorescence imaging across violet (405nm), green (542nm), and red (610nm) LEDs with a 5MPx monochrome CMOS sensor, paired with a proprietary cloud-based machine learning algorithm that produces HbO2 absorption maps and biopsy-site guidance in real time. Sascan is extending this platform into CerviScan (cervical cancer screening, currently under a 5-institution ICMR multi-centric trial under the Medtech Mitra scheme) and a parallel Photobiomodulation Therapy (PBMT) wellness family — CureLite (FDA-approved, Class 3B laser), CureWrap, CureLaze, and the upcoming VagusLite vagus nerve stimulation device. CerviScan pilot data at Kasturba Medical College (109 patients) reported 100% sensitivity and 93% specificity.

The business model is a hybrid of B2B hardware sales and consumer D2C wellness commerce. OralScan and CerviScan are sold quote-based to dental colleges, cancer hospitals, and individual practitioners via "Request a demo" / "Get a free Quote" CTAs routed to WhatsApp and email, with an implicit recurring/usage-based component tied to cloud-based ML screening. The Cure* wellness line (CureLite, CureWrap, CureLaze, VagusLite) is sold direct-to-consumer through WhatsApp commerce for pain relief, inflammation reduction, and vagus nerve support. Customer segments span dental education (Sree Balaji, Dayanand Sagar, Ahmedabad Dental, GDC Thiruvananthapuram), oncology hospitals (Meherbai Tata Memorial, Nellai Cancer Institute, IMS and SUM Hospital), non-profits (Ekohum Foundation), and consumer wellness buyers. Clinical validation is anchored in ICMR's Medtech Mitra scheme and university hospital partners, and the company is supported by a board of advisors from HCG Cancer Centre, Forus Health, and Kolkata Ventures.

Operationally, Sascan is a sub-20-person organization (founder-led, with a lean technical and clinical-affairs team) backed by modest disclosed capital (Unicorn India Ventures, DST grants, CSIRO Innovate to Grow selection), with revenue undisclosed and commercial scale still nascent despite a clear regulatory and product milestone cadence.

Name

Sascan Meditech

Legal name

Sascan Meditech Pvt. Ltd.

Website

https://sascan.in

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Sascan Meditech is an Indian medtech startup developing CE-marked multimodal optical imaging devices with cloud-based ML for non-invasive oral and cervical cancer screening, alongside a photobiomodulation wellness product line sold to dental colleges, hospitals, and consumers.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Devices

akta.pro primary industry

Oral Cancer Screening (HLABAHAF)

akta.pro secondary industries

Dental Imaging Interpretation & Teleradiology Services (HLABAIAK), Intraoral Optical Scanning & Digital Impression Centers (HLABAIAE)

Keywords

• Oral cancer screening
• Cervical cancer screening
• Multispectral imaging
• Photobiomodulation therapy
• Medical diagnostic devices

Headquarters

HQ city

Trivandrum

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Hardware sales of medical devices: One-time capital equipment sales of flagship OralScan (CE-marked) and the broader product family (CerviScan, CureLite, CureWrap, CureLaze, VagusLite) to dental colleges, hospitals, cancer centres, and individual practitioners. Devices are positioned as affordable point-of-care screening equipment.
2. Cloud-based ML screening service: Recurring/usage-based revenue potential from the cloud-based Machine Learning algorithm that analyses captured images and provides real-time tissue classification, paired with OralScan deployment. Implicit SaaS component tied to each screening.
3. Direct-to-consumer wellness device sales: Direct retail of consumer wellness/PBM products (CureLite, CureWrap, CureLaze, VagusLite) sold via WhatsApp commerce ("Shop Now"), targeting individuals for pain relief, inflammation reduction, and vagus nerve support.

Pricing tiers

Go-to-market motion1 record

Marketing channels7 records

Core offering

Sascan Meditech designs and manufactures CE-marked and FDA-approved medical devices that use a patented multispectral optical imaging platform paired with a cloud-based machine-learning algorithm for non-invasive screening of oral and cervical cancers. Its flagship OralScan is a handheld multimodal imaging device for early oral cancer detection and biopsy guidance, complemented by a Photobiomodulation Therapy (PBMT) product family (CureLite, CureWrap, CureLaze, VagusLite) targeting pain relief, wellness, and vagus nerve stimulation.

Product overview

Sascan Meditech offers a multi-product medical device portfolio centered on a proprietary multispectral/multimodal imaging technology platform, anchored by its flagship OralScan oral cancer screening device (CE Marked) and the in-validation CerviScan cervical cancer screening device. This diagnostic core is paired with a Photobiomodulation Therapy (PBMT) wellness product family — CureLite (FDA-approved, class 3B laser), CureWrap (flexible LED wrap), and CureLaze (intranasal low-level laser) — plus the upcoming VagusLite, a PBM-based vagus nerve stimulation device for gut health and mood disorders. Together, these products span early cancer detection (oral and cervical) through ML-driven optical biopsy guidance, and adjacent light-based therapy and wellness applications, all built on Sascan's biophotonics expertise and operated from its Thiruvananthapuram facility.

Differentiator

Problem solved

Functional benefit

Brands

• OralScan: Handheld multimodal imaging device for non-invasive, real-time oral cancer screening and biopsy guidance, powered by multispectral imaging and a cloud-based machine-learning algorithm. CE-marked product.
• CerviScan
• CureLite
• CureLaze
• CureWrap
• VagusLite

Products and services

• OralScan Hand-held, non-invasive, multimodal optical imaging device for early detection of (pre-)cancerous lesions of the oral cavity and biopsy guidance. Uses diffuse reflectance and tissue autofluorescence with violet (405nm), green (542nm), and red (610nm) LEDs and a 5MPx monochrome CMOS sensor; CE Marked; powered by a cloud-based machine-learning algorithm that delivers real-time tissue classification and HbO2 absorption maps. Designed for portable use with a Windows tablet/laptop by trained health workers and dental practitioners.
• CerviScan Hand-held non-invasive optical imaging device for cervical cancer screening and early detection. Captures fluorescence and diffuse reflectance images in vivo via an inserted speculum, using LED sources centred on PpIX and oxy/deoxy-haemoglobin absorption peaks. Proprietary ML algorithm grades cervical intraepithelial neoplasia (CIN) and guides biopsy site selection. Currently under multi-centric clinical validation (CDSCO approval pending).
• CureLite Class 3B Photobiomodulation Therapy (PBMT) laser device, FDA-approved, featuring four 808nm and twelve 650nm laser diodes (660mW total power). Provides anti-inflammation and pain relief for muscles/joints, rapid superficial wound healing, with contact/non-contact modes, programmable 0-30 minute timer, and 2600mAh lithium battery delivering ~4 days of usage.
• CureWrap Flexible wrap-around Photobiomodulation (PBM) device with an array of 120 LEDs (660nm red and 850nm near-infrared; 360 chips in a 40x20cm panel), delivering 500mW per LED and 150mW/cm2 irradiance at surface. Rechargeable 3600mAh power bank with Type-C charging; programmable CW or pulsed modes with 15-minute auto shut-off; for pain relief, inflammation reduction, skin rejuvenation, and weight/hair applications.
• CureLaze Advanced low-level laser therapy device delivering non-invasive intranasal light therapy to support healthy blood circulation, reduce hyperviscosity/hyperlipidemia, improve microcirculation, and aid in management of high blood pressure, stroke prevention, rhinitis, and diabetic microangiopathy via semiconductor laser irradiation.
• VagusLite Photobiomodulation (PBM)-based, non-invasive vagus nerve stimulation device in an ergonomic wearable neck-collar form factor. Uses a dual-wavelength system with 810nm near-infrared LEDs targeting the carotid triangle region and intranasal 650nm red light therapy, supporting vagal function for gut health and mood disorders via cytochrome c oxidase activation and ATP enhancement.

Quantifiable outcome

• 100% sensitivity and 93% specificity in discriminating normal from abnormal (precancer and cancer) cervix in 109-patient pilot study at Kasturba Medical College, Manipal (CerviScan).
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered minor, flagship and core.

• ALTDATAminorStrategic or Co-development PartnerSascan Meditech and ALTDATA were jointly selected for the CSIRO Innovate to Grow – Innovation Program (Health Care Innovation Program). This is a co-participation in an innovation accelerator rather than a commercial channel.
• SCTIMST (Sree Chitra Tirunal Institute for Medical Sciences and Technology) — TIMed incubatorflagshipStrategic or Co-development PartnerSascan's registered office and operating facility is hosted at TIMed, 5th Floor, MSV Building, SCTIMST, Poojapura, Thiruvananthapuram. TIMed is SCTIMST's technology business incubator; housing at SCTIMST gives the company access to medtech R&D infrastructure and clinical collaborators.
• Indian Council for Medical Research (ICMR), Government of India — Medtech Mitra schemeflagshipStrategic or Co-development PartnerMulti-centric trial covering 5 institutions is being conducted under ICMR's Medtech Mitra scheme to develop the CerviScan algorithm and validate the device. Key government partnership enabling clinical validation and eventual market entry.
• Kasturba Medical College, ManipalcoreImplementation/ SI/ Consulting PartnerHosted the CerviScan pilot studies with the first prototype in 109 patients. Results: 100% sensitivity and 93% specificity in discriminating normal from abnormal (precancer and cancer) cervix; published in the Artificial Intelligence in Health journal (Phebe et al, 2025).
• SAT Hospital, Government Medical College, ThiruvananthapuramcoreImplementation/ SI/ Consulting PartnerConducted CerviScan Phase-1 trial in 500 women at this government teaching hospital.
• Dr Vishal Rao U.S. (HCG Cancer Centre Bangalore)minorStrategic or Co-development PartnerHead & Neck Surgeon at HCG Cancer Centre Bangalore; serves on Sascan's Board of Advisors, providing strategic clinical insight.
• Dr. Shyam Vasudev Rao (Forus Health, Renalyx Systems)minorStrategic or Co-development PartnerFounder Director of Forus Health Pvt Ltd & Renalyx Systems Pvt Ltd, Bangalore; serves on Sascan's Board of Advisors.
• Avelo Roy (Kolkata Ventures)minorStrategic or Co-development PartnerMD of Kolkata Ventures and former Startup Advisor of the Prime Minister of Nepal; serves on Sascan's Board of Advisors, providing strategic and investor-network insight.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Forward Science (OralID): Forward Science's OralID is a handheld fluorescence-based oral cancer screening device widely used in US dental practices. Directly comparable to Sascan's OralScan in target user (general dentists), screening modality (optical/fluorescence), and use case (early oral lesion detection).
• LED Dental (VELscope Vx): VELscope Vx is the longest-standing fluorescence visualization adjunct for oral cancer screening, sold across North America and Europe. Directly comparable to OralScan in clinical workflow (chairside fluorescence screening) and target customer (dental clinicians).
• DentalEZ (Identafi): Identafi uses multi-wavelength (white, violet, amber) optical screening for oral cancer, making it the closest multispectral analog to Sascan's OralScan platform. Directly comparable in technology stack, target customer, and clinical use case.
• AdDent: AdDent manufactures handheld dental diagnostic and screening devices including optical caries/cancer detection tools. Comparable to Sascan in product format (compact dental diagnostic hardware) and dental-channel go-to-market.
• TruScreen Limited: TruScreen manufactures a real-time, non-invasive cervical cancer screening device that uses optical/electrical tissue measurements without requiring cervical sampling. The closest direct functional analog to CerviScan's handheld cervical screening proposition.
• MobileODT (EVA System): MobileODT's EVA System is a smartphone colposcope with AI-based cervical visualization for use in low-resource settings — directly comparable to CerviScan's cloud-ML cervical screening approach, target segment (underserved women), and emerging-market GTM.
• Aindra: Aindra is an India-based medtech startup applying AI-driven diagnostics to cervical and other cancers. Comparable to Sascan as a fellow Indian AI-cancer-screening startup targeting similar hospital/public-health customers and cervical cancer workflow.
• Thor Photomedicine: Thor is a leading global manufacturer of PBM/LLLT devices used by clinicians and consumers for pain, inflammation, and tissue repair. Closest direct competitor to Sascan's CureLite/CureWrap/CureLaze PBM product family in technology, indications, and channels.
• Multi Radiance Medical: Multi Radiance manufactures FDA-cleared PBM/LLLT devices combining super-pulsed lasers and LEDs for pain management and rehab. Directly comparable to CureLite/CureWrap in device class, regulatory positioning, and customer base.

Broad incumbents

• Hologic: Hologic is a global leader in women's health diagnostics, including the ThinPrep Pap test and molecular cervical cancer screening. A broad incumbent that defines the cervical screening standard CerviScan must displace or partner with; comparable in target disease and customer segment but vastly larger in scale, product breadth, and reimbursement footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/Sascanmeditech
• YouTubeyoutube.com/channel/UCM6I548_6yxXqXrfodbqbww
• Facebookfacebook.com/sascanmeditech
• LinkedInlinkedin.com/company/sascan-meditech-pvt.-ltd.
• Instagraminstagram.com/sascan_meditech

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sascan Meditech